Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
GANX | Gain Therapeutics, Inc. | Director | $1.17M | Jul 1, 2024 | ||
NBSE | NeuBase Therapeutics, Inc. | Director | Sep 9, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|